Figure 2.
A comparison of the regulatory expectations for a novel molecular entity (drug or biologic), for a classic small molecule generic, and for a biosimilar/interchangeable biologic. The latter shares attributes of the other two.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.